Answers are grounded in this paper and cite their sources.
This novel method combines biosynthesis and dyeing of indigoids in E. coli, simplifying processes and enhancing sustainability.
Abstract The textile dyeing industry, empowered by synthetic chemistry, has shaped modern aesthetics through vibrant coloration technologies. Indigoid dyes, including indigo and Tyrian purple, embody this potential but are hindered by the toxic, hazardous chemo-synthesis and water-intensive chemo-dyeing processes. While biosynthesis and bio-dyeing efforts mitigate hazardous inputs, they remain constrained by disjointed synthesis-dyeing steps that lead to unsustainable water and energy demands. Also, the disadvantages of biosynthetic pathways including complexity, low atom economy, and inefficiency still remain. Here, we pioneer a one-pot, one-step approach for unifying biosynthesis and bio-dyeing of indigoid which circumvent water usage in the dyeing process. By combining alcohol dehydrogenase-catalyzed amino alcohol oxidation with flavin monooxygenase-driven indole oxygenation, we constructed a previously unreported artificial redox-neutral cascade biosynthetic pathway to produce indigoids. This innovation significantly simplified the catalytic process and achieved the highest reported atom economy and production efficiency of indigoids. Employing E. coli whole cell that generate biosynthetic bluish-violet indigoid dyes, we achieved biosynthesis and in situ dyeing of indigoids on various natural and synthetic fabrics. Crucially, this system successfully dyed synthetic nylon fibers with the historic purple hue—a milestone unattainable through conventional chemical methods.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: